Advanced Oncotherapy (AVO) – Conversion of Convertible Loan Notes
Advanced Oncotherapy (AIM: AVO), the developer of next-generation proton therapy systems for cancer treatment, announces that Bracknor Investment Group has advised the Company that they will convert a portion of the first tranche of the Convertible Loan Notes issued to them on 22 February 2017 into new ordinary shares of 25p each in the share capital of […]
Advanced Oncotherapy (AVO) – Conversion of loan notes
Advanced Oncotherapy (AIM: AVO), the developer of next-generation proton therapy systems for cancer treatment, announces thatBracknor Investment Group has advised the Company that they will convert a portion of the first tranche of the Convertible Loan Notes issued to them on 22 February 2017 into new ordinary shares of 25p each in the share capital of […]
Advanced Oncotherapy (AVO) – Conversion of loan notes
Advanced Oncotherapy (AIM: AVO), the developer of next-generation proton therapy systems for cancer treatment, announces thatBracknor Investment Group has advised the Company that they will convert a portion of the first tranche of the Convertible Loan Notes issued to them on 22 February 2017 into new ordinary shares of 25p each in the share capital of […]
Advanced Oncotherapy (AVO) – Conversion of loan notes
Advanced Oncotherapy (AIM: AVO), the developer of next-generation proton therapy systems for cancer treatment, announces that Bracknor Investment Group has advised the Company that they will convert a portion of the first tranche of the Convertible Loan Notes issued to them on 22 February 2017 into new ordinary shares of 25p each in the share […]
Advanced Oncotherapy (AVO) – Result of General Meeting
Advanced Oncotherapy plc (AIM: AVO), the developer of next generation proton therapy systems for cancer treatment, announces that at the General Meeting held earlier today all resolutions were passed.download full film iBoy As a result the Board now has authority to utilise the Equity Financing Facility provided by Bracknor, details of which were provided in […]
Advanced Oncotherapy (AVO) – Updated major shareholder list to include Bracknor Investment Group
Advanced Oncotherapy (AVO) – Major Shareholders Shares in issue: 72,467,783 Major Shareholders Information Shareholder Number of Shares % of Total In Issue Brahma AG 10,850,491 15.0% Mr Michael Stephen Bradfield 7,080,740 9.8% MK Trust Co., LTD 4,850,000 6.7% Michael Sinclair & Family 4,628,229 6.4% Banca Profilo SPA 3,750,000 5.2% Hargreaves Lansdown Asset Mgt 3,592,410 5.0% […]
Advanced Oncotherapy (AVO) – Posting of Circular, Notice of General Meeting and Update on Financing Options
Advanced Oncotherapy (AIM: AVO), the developer of next-generation proton therapy systems for cancer treatment, announces that a circular containing a Notice of General Meeting has been posted to Shareholders. The purpose of the Circular is to explain the background to the proposed Equity Financing Facility with Bracknor announced on 22 February 2017 and why the […]
Advanced Oncotherapy (AVO) – Conversion of convertible loan notes
Advanced Oncotherapy (AIM: AVO), the developer of next-generation proton therapy systems for cancer treatment, announces that Bracknor Investment Group has advised the Company that they will convert a portion of the first tranche of the Convertible Loan Notes issued to them on 22 February 2017 into new ordinary shares of 25p each in the share […]
Advanced Oncotherapy (AVO) – Update on financing and Harley Street building work update
Advanced Oncotherapy (AVO), the developer of next generation proton therapy systems for cancer treatment, announces that further to the financing agreement with Bracknor announced on 22 February 2017, the first tranche has been drawn down by the Company and the initial funds of £1.3 million received (less 5%, in accordance with terms for receipt of […]
Advanced Oncotherapy (AVO) – Financing agreement
Advanced Oncotherapy plc (AIM: AVO), the developer of next generation proton therapy systems for cancer treatment, announces it has secured a flexible and staged £26 million financing agreement with Bracknor Investment Group, a Dubai-based investment firm. The Agreement gives the Company the ability to issue a minimum of £13 million in convertible loan notes (Minimum […]